← Back to Clinical Trials
Recruiting NCT05801432

NCT05801432 A Study to Evaluate Coronary Atherosclerosis in Patients With Diabetes Mellitus

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05801432
Status Recruiting
Phase
Sponsor Asan Medical Center
Condition Diabetes Mellitus
Study Type OBSERVATIONAL
Enrollment 511 participants
Start Date 2021-08-24
Primary Completion 2026-12-31

Trial Parameters

Condition Diabetes Mellitus
Sponsor Asan Medical Center
Study Type OBSERVATIONAL
Phase N/A
Enrollment 511
Sex ALL
Min Age 19 Years
Max Age N/A
Start Date 2021-08-24
Completion 2026-12-31

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The purpose of this study is to evaluate the natural history of coronary atherosclerosis development and progression over time by CCTA and to identify risk factors attributable to the development of coronary atherosclerosis in a Korean DM population.

Eligibility Criteria

Inclusion Criteria: * Age 19 years or older * Asymptomatic patients with type 2 DM who had undergone initial CCTA evaluation at the Diabetes Center of the Asan Medical Center between February 2008 and June 2012 * Willing and able to provide informed written consent Exclusion Criteria: * Blood test results that the Creatinine level exceeds 1.5 mg/dL * A person with a history of anaphylaxis or allergic shock associated with a contrast medium * Pregnant women * Unable to undergo follow-up CCTA * Uninterpretable CCTA

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology